ContraFect to Present at Piper Jaffray Health Care Conference

YONKERS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech

PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech ...

Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech

PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech ...